http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5985a09614205c7ff8620d6f27bc5e6
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | L Coleman Coleman |
| name | Robert L. Coleman Robert L Coleman |
| given-name | Robert L Robert Robert L. |
| organization-name | Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, and 3Experimental Therapeutics; 4Center for RNA Interference and Non-Coding RNA, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 5Department of Pathology and 6Medicine, University of Southern California; and 7Vasgene Therapeutics, Los Angeles, California Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; and Departments of 2Gynecologic Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Non-Coding RNA, U.T.M.D. Anderson Cancer Center, Houston, Texas Authors' Affiliations: Departments of 1Bioinformatics and Computational Biology, 2Gynecologic Oncology and Reproductive Medicine, 3Experimental Therapeutics, 4Cancer Biology, and 5Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 6Fred Hutchinson Cancer Research Center, Seattle, Washington US Oncology Research, The Woodlands, Texas. The University of Texas MD Anderson Cancer Center, Houston, Texas. MD Anderson Cancer Center, Houston, TX Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Texas Southwestern, Dallas, TX 75390, USA Authors' Affiliations: Departments of 1Gynecologic Oncology and 2Cancer Biology, and 3Center for RNAi and Non-Coding RNA, M.D. Anderson Cancer Center, and 4Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Baylor College of Medicine, Houston, Texas; and 5Cancer Research, GlaxoSmithKline, Collegeville, Pennsylvania US Oncology Research and Gynecologic Oncology Group Foundation, The Woodlands, TX, USA. Sarah Cannon Research Institute, Nashville, Tennessee, USA. 1The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Gynecologic Oncology and Departments of 2Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas.; 3Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas. 1Departments of Gynecologic Oncology and Reproductive Medicine, Department of Gynecologic Oncology and Reproductive Medicine University of Texas M. D. Anderson Cancer Center Houston TX From the Department of Gynecologic Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas. Joyce F. Liu, Dana-Farber Cancer Institute, Boston; Isabelle Tabah-Fisch and Joseph Pearlberg, Sanofi Oncology; Victor Moyo, Kaveh Riahi, Rachel Nering, William Kubasek, Bambang Adiwijaya, Akos Czibere, and Gavin MacBeath, Merrimack Pharmaceuticals, Cambridge, MA; R. Wendel Naumann, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC; Robert L. Coleman, MD Anderson Cancer Center, Houston, TX; Isabelle Ray-Coquard, Centre Léon Bérard, University Claude Bernard, and Groupe d’Investigateurs... From the Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M.D. Anderson Cancer Center, Houston (P.T.R., M.F., R.L.C.); the Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Bogota, and Clínica de Oncología Astorga, Medellin — both in Colombia (R.P.); the Department of Gynecologic Surgery, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (A.L.); the Department of Gynecologic Oncology, Barretos Cancer Hospital, Barretos (M.V.), the Department... US Oncology Research, Houston, Texas. The University of Texas MD Anderson Cancer Center, Houston, TX. MD Anderson Division of Radiation Oncology, Houston, Texas, USA. Alexi A. Wright, Dana-Farber Cancer Institute, Harvard Medical School; Don S. Dizon, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Deborah K. Armstrong, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Michael A. Bookman, US Oncology Research and Arizona Oncology, Tucson, AZ; William A. Cliby, Mayo Clinic, Rochester, MN; Robert L. Coleman and Larissa A. Meyer, The University of... University of Texas, MD Anderson Cancer Center, Houston Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. [email protected] Department of Gynecologic Oncology & Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA 1Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Genitourinary Medical Oncology, 3Bioinformatics and Computational Biology, and 4Cancer Biology; 5Division of Cancer Medicine; 6Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; 7Kinex Pharmaceuticals LLC, New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, New York; 8Department of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei; 9Department of Gynecology, Obstetrics and Gynecology, Hospital of Fudan University, Shanghai, P.R. China US Oncology Research, The Woodlands, TX, USA 1Gynecologic Oncology, Departments of Authors' Affiliations: 1Morristown Medical Center, Women's Cancer Center, Morristown, New Jersey; and 2MD Anderson Cancer Center, Department of Gynecologic Oncology, University of Texas, Houston, Texas Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas, MD Anderson Cancer Center, 1155 Herman Pressler Drive, CPB 6.3590, Houston, TX 77030, USA Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine and 2Cancer Biology, 3Center for RNA Interference and Non-Coding RNA, the University of Texas MD Anderson Cancer Center, Houston, Texas; 4University of Southern California, Los Angeles, California; 5Department of Obstetrics and Gynecology, Dongguk University; Departments of 6Systems Biology and 7Obstetrics and Gynecology, Konkuk University, Seoul, Korea; and 8Department of Obstetrics and Gynecology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand GOG-F and Gynecologic Oncology & Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA. All authors: University of Texas MD Anderson Cancer Center, Houston, TX. Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Systems Biology, 3Pathology, 4Experimental Therapeutics, 5Bioinformatics and Computational Biology, 6Cancer Biology, 7Thoracic/Head and Neck Medical Oncology, and 8The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas MD Anderson Cancer Center, Department of Gynecologic Oncology & Reproductive Medicine, 1155 Herman Pressler Dr, CPB 6.3590, Houston, TX, USA Department of Gynecologic Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA University of Texas, MD Anderson Cancer Center, Houston, Texas, USA 2Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas. Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA US Oncology Research, The Woodlands, TX 77380, USA The University of Texas MD Anderson Cancer Center, Houston, TX Brian M. Slomovitz, Yunyun Jiang, Melinda S. Yates, Pamela T. Soliman, Taren Johnston, Charles Levenback, Qian Zhang, Kari Ring, Mark F. Munsell, David M. Gershenson, Karen H. Lu, and Robert L. Coleman, The University of Texas MD Anderson Cancer Center, Houston, TX; Brian M. Slomovitz and Maureen Nowakowski, Morristown Medical Center, Morristown, NJ; and Brian M. Slomovitz, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL. 16Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. The Oklahoma Medical Research Foundation, Hematology Research Laboratories, Oklahoma City, Oklahoma 73104, and the NASA – Lyndon B. Johnson Space Center, Biomedical Research Division, DB-7, Houston, Texas 77058, U.S.A. a The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA Thorndike Memorial Laboratory 2nd and 4th Harvard Medical Services Boston City Hospital Boston, Mass. 02118 Department of Gynecological Oncology & Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX 10 From the Department of Gynecologic Oncology, Department of Diagnostic Imaging, and Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston; and Division of Gynecologic Oncology and Department of Diagnostic Imaging, The University of Texas Southwestern Medical Center, Dallas, TX. Authors' Affiliations: Departments of 1Gynecology and 2Investigational Cancer Therapeutics (A Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas; and 3Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Wright State University Boonshoft School of Medicine, Dayton, Ohio Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, The University of Texas, Houston; Now with US Oncology Research, The Woodlands, Texas Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; 2Department of Gynecologic Oncology, U.T.M.D. Anderson Cancer Center, Houston, Texas; 3Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; 4Department of Experimental Therapeutics, U.T.M.D. Anderson Cancer Center, Houston, Texas; 5The University of Puerto Rico Comprehensive Cancer Center, Rio Piedras, PR; and 6Center for RNA Interference and Non-Coding RNA; 7Department of Cancer Biology, U.T.M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; 2Department of Gynecologic Oncology, U.T.M.D. Anderson Cancer Center, Houston, Texas; 3Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; 4Department of Experimental Therapeutics, U.T.M.D. Anderson Cancer Center, Houston, Texas; 5The University of Puerto Rico Comprehensive Cancer Center, Rio Piedras, PR; and 6Center for RNA Interference and Non-Coding RNA; 7Department of Cancer Biology, U.T.M.D. Anderson Cancer Center, Houston, Texas US Oncology Research, The Woodlands, Texas The University of Texas MD Anderson Cancer Center, Houston GOG-F and Gynecologic Oncology & Reproductive Medicine, University of Texas; M.D. Anderson Cancer Center, Houston, Texas, USA. Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Drive CPB6.3244, Houston, TX 77030–3721, USA. Orion Research, Inc. 380 Putnam Ave. Cambridge, Mass. 02139 Bradley J. Monk, University of Arizona Cancer Center at Dignity Health St Joseph’s Hospital and Medical Center, Phoenix, AZ; Michael W. Sill, Roswell Park Cancer Institute, Buffalo; Carol Aghajanian, Memorial Sloan Kettering Cancer Center, New York, NY; Joan L. Walker, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Christopher J. Darus, Maine Medical Center, Portland, ME; Gregory Sutton, Washington University School of Medicine, St. Louis, MO; Krishnansu S. Tewari, University of... Texas Oncology, US Oncology Research , TX , USA Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Charles F. Levenback and Robert L. Coleman, The University of Texas MD Anderson Cancer Center, Houston, TX; Shamshad Ali, Gynecologic Oncology Group Statistical & Data Center, Roswell Park Cancer Institute, Buffalo; Mario M. Leitao Jr, Memorial Sloan-Kettering Cancer Center, New York, NY; Michael A. Gold, University of Oklahoma, Oklahoma City, OK; Jeffrey M. Fowler, The Ohio State University Columbus Cancer Council, Hilliard, OH; Patricia L. Judson, University of Minnesota School of Medicine,... Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston Authors' Affiliations: 1Department of Gynecologic Oncology, 2Department of Cancer Biology, and 3Center for RNA Interference and Non-Coding RNA, University of Texas M.D. Anderson Cancer Center; 4Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 5Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine; 6Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine; 7Department of Obstetrics and Gynecology, Yonsei University College of Medicine; 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, South Korea; 9Department of Obstetrics and Gynecology, Dongguk University Ilsan Hospital, Goyang, South Korea; and 10Medimmune, LLC, Gaithersburg, Maryland Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Hematology and Oncology, 3Biostatistics, 4Cancer Biology, and 5Pathology, and 6The Center for RNA Interference and Non-Coding RNAs; The University of Texas MD Anderson Cancer Center, Houston, Texas Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, 3Pathology, and 4Experimental Therapeutics, 5Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 6Center for Reproductive Sciences, University of California, San Francisco, California R. Wendel Naumann and James T. Symanowski, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC; Robert L. Coleman, MD Anderson Cancer Center, University of Texas, Houston; Michael G. Teneriello, Texas Oncology, Austin, TX; Robert A. Burger, Fox Chase Cancer Center, Philadelphia, PA; Edward A. Sausville, Greenebaum Cancer Center, University of Maryland, Baltimore, MD; Elzbieta Kutarska, Centrum Onkologii Ziemi Lubelskiej, Lubland; Elzbieta Nowara, Instytut im. Marii Skłodowskiej-Curie,... 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA US Oncology Network, The Woodlands, Texas. Department of Gynecologic Oncology and Reproductive Medicine The University of Texas MD Anderson Cancer Center Houston Texas Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, USA From the University of Texas M.D. Anderson Cancer Center, Houston (R.L.C., K.B.-E.); Women’s Cancer Center of Nevada, Las Vegas (N.M.S.); NRG Oncology Statistical and Data Management Center, Roswell Park Cancer Institute, Buffalo (D.E., H.Q.H., M.F.B.), and Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (P.S.) — both in New York; the University of Cincinnati, University of Cincinnati Cancer Institute, Cincinnati (T.J.H.); the Sidney Kimmel Comprehensive Cancer Center... Department of Gynecologic Oncology, Division of Surgery, UT M.D. Anderson Cancer Center From the University of Texas M.D. Anderson Cancer Center, Houston (R.L.C.); University of Chicago Medicine (G.F.F.) and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University (D.C.), Chicago, and AbbVie, North Chicago (D.M.S., B.A.B., S.B., C.K.R., P.J.A., M.H.D.) — all in Illinois; NRG Oncology Statistical and Data Center, Roswell Park Cancer Institute, Buffalo (M.F.B.), and Memorial Sloan Kettering Cancer Center, New York (K.B.-M., C.A.) — both in New York; University of... |
Incoming Links
Showing number of triples: 1 to 504 of 504.